Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Predictive Value of Excision Repair Cross-complementing Rodent Repair Deficiency Complementation Group 1 and Ovarian Cancer Risk

  • He, Shan-Yang (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University) ;
  • Xu, Lin (Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University) ;
  • Niu, Gang (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University) ;
  • Ke, Pei-Qi (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University) ;
  • Feng, Miao-Miao (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University) ;
  • Shen, Hong-Wei (Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University)
  • Published : 2012.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: We aimed to analyze the association between excision repair cross-complementing rodent repair deficiency complementation group 1 (XRCC1) and ovarian cancer risk. Methods: We performed a hospital-based case-control study with 155 cases and 313 controls in China. All Chinese cases with newly diagnosed primary ovarian cancer between May 2005 to May 2010 in our hospital were invited to participate within 2 months of diagnosis. Controls were randomly selected from people who requested general health examinations in the same hospital during the same period. SNPs in EXCC1, ERCC1 C8092A and ERCC1 T19007C, were analyzed by PCR-RFLP method. Results: We observed a non-significantly increased risk of ovarian cancer among individuals with ERCC1 8092TT compared with those with the 8092CC genotype (adjusted OR=1.55, 95% CI%=0.74-2.97). Moreover, 19007TT genotype carriers also showed a non-significant increased risk of ovarian cancer over those with the 19007CC genotype (adjusted OR=1.78, 95% CI%=0.91-3.64). Conclusion: Our firstly investigation of links between polymorphisms in the ERCC1 gene and the risk of ovarian cancer in Chinese population demonstrated no significant association. Further large sample studies in Chinese populations are needed.

Keywords

References

  1. Avraam K, Pavlakis K, Papadimitriou C, et al (2011). The prognostic and predictive value of ERCC-1, p53, bcl-2 and bax in epithelial ovarian cancer. Eur J Gynaecol Oncol, 32, 516-20.
  2. Bessho T, Sancar A, Thompson LH, et al (1997). Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J Biol Chem, 272, 3833-7. https://doi.org/10.1074/jbc.272.6.3833
  3. Jin F, Shu XO, Devesa SS, et al (1993). Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972-89. Cancer Causes Control, 4, 355-60. https://doi.org/10.1007/BF00051338
  4. Krivak TC, Darcy KM, Tian C, et al (2008). Gynecologic Oncology Group Phase III Trial.Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer. J Clin Oncol, 26, 3598-606. https://doi.org/10.1200/JCO.2008.16.1323
  5. Lin F, Lin K, Xie X, et al (2010). Increased ERCC1 protein expression is associated with suboptimal debulking in advanced epithelial ovarian cancer. Anticancer Res, 30, 2447-52.
  6. Li QQ, Yunmbam MK, Zhong X, et al (2001). Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression. Cell Mol Biol (Noisy-le-grand), 47, OL61-72.
  7. Liu Y, Scheurer ME, El-Zein R, et al (2009). Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev, 18, 204-14. https://doi.org/10.1158/1055-9965.EPI-08-0632
  8. Matullo G, Guarrera S, Sacerdote C, et al (2005). Polymorphisms/ haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev, 14, 2569-78. https://doi.org/10.1158/1055-9965.EPI-05-0189
  9. Moreno V, Gemignani F, Landi S, et al (2006). Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res, 12, 2101-8. https://doi.org/10.1158/1078-0432.CCR-05-1363
  10. Rajaraman P, Hutchinson A, Wichner S, et al (2010). DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol, 12, 37-48. https://doi.org/10.1093/neuonc/nop012
  11. Reed E, Yu JJ, Davies A, et al (2003). Clear cell tumors have higher mRNA levels of ERCC1 and XPB than other histological types of epithelial ovarian cancer. Clin Cancer Res, 9, 5299-305.
  12. Ries LAG, Young JL, Keel GE, et al (2007). SEER Program, NIH Pub. No. 07-6215. National Cancer Institute; Bethesda, MD: 2007. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics.
  13. van Duin M, de Wit J, Odijk H, et al (1986). Molecular characterization of the human excision repair gene ERCC- 1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell, 44, 913-23. https://doi.org/10.1016/0092-8674(86)90014-0
  14. Weberpals J, Garbuio K, O'Brien A, et al (2009). The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer. Int J Cancer, 124, 806-15. https://doi.org/10.1002/ijc.23987
  15. Wilson MD, Ruttan CC, Koop BF, et al (2001). ERCC1: a comparative genomic perspective. Environ Mol Mutagen, 38, 209-15. https://doi.org/10.1002/em.1073
  16. Zhou W, Liu G, Park S, et al (2005). Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev, 14, 491-6. https://doi.org/10.1158/1055-9965.EPI-04-0612
  17. Zienolddiny S, Campa D, Lind H, et al (2006). Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 27, 560-7. https://doi.org/10.1093/carcin/bgi232

Cited by

  1. Comprehensive Study on Associations Between Nine SNPs and Glioma Risk vol.13, pp.10, 2012, https://doi.org/10.7314/APJCP.2012.13.10.4905
  2. Association of Rs11615 (C>T) in the Excision Repair Cross-complementing Group 1 Gene with Ovarian but not Gynecological Cancer Susceptibility: a Meta-analysis vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6071
  3. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy vol.35, pp.4, 2014, https://doi.org/10.1007/s13277-013-1378-7
  4. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility vol.38, pp.3, 2018, https://doi.org/10.1042/BSR20180114